IGC Pharma, Inc. (IGC) Financials
IGC Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 9.5 million | 3.4 million |
| March 31, 2026 | 9.2 million | 3.1 million |
| Dec. 31, 2025 | 9.7 million | 2.3 million |
| Sept. 30, 2025 | 9.7 million | 1.7 million |
IGC Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 1.4 million | -1.0 million |
| March 31, 2026 | -1.4 million | 1.0 million |
| Dec. 31, 2025 | -1.2 million | 926000 |
| Sept. 30, 2025 | -2.1 million | 730000 |
IGC Net Income
No data available :(
IGC Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 354000 | 149000 | 5000 |
| March 31, 2026 | 235000 | 191000 | 16000 |
| Dec. 31, 2025 | 938000 | 131000 | 2000 |
| Sept. 30, 2025 | 1.1 million | 132000 | 5000 |
IGC Shares Outstanding
IGC Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 170000 | 1.4 million | 1.4 million | - |
| March 31, 2026 | 170000 | 1.3 million | 1.2 million | - |
| Dec. 31, 2025 | 12000 | 1.5 million | 1.5 million | - |
| Sept. 30, 2025 | 29000 | 1.6 million | 1.4 million | - |
IGC Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 265000 | 217000 |
| March 31, 2026 | 317000 | 262000 |
| Dec. 31, 2025 | 350000 | 306000 |
| Sept. 30, 2025 | 191000 | 92000 |
IGC Revenue by Segment
Graph available only for paid members. Upgrade to see it.
IGC
Price: $0.25
52 week price:
Earnings Per Share: -0.06 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 122069
Market Capitalization: 28.0 million